Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica

International Journal of Infectious Diseases

Volumn 11, Issue 3, 2007, Pages 220-225

  Brown, Paul D ^a   Ngeno, Charles ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial; Methicillin resistance; MRSA; MSSA; Staphylococcus aureus

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; NITROFURANTOIN; OXACILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; JAMAICA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; JAMAICA; MALE; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34247210810     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2006.04.005     Document Type: Article

References (40)

1. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
2. Waldvogel F.A. Staphylococcus aureus (including toxic shock syndrome). In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. (1995), Churchill Livingstone, New York 754-777
3. Jevons M.P. 'Celbenin'-resistant staphylococci. Br Med J 1 (1961) 124-125
4. Hartman B.J., and Tomasz A. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother 29 (1986) 85-92
5. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 (2001) 178-182
6. Groom A.V., Wolsey D.H., Naimi T.S., Smith K., Johnson S., Boxrud D., et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286 (2001) 1201-1205
7. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 (1998) 593-598
8. Moreno F., Crisp C., Jorgensen J.H., and Patterson J.E. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 21 (1995) 1308-1312
9. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
10. Brown P.D., and Izundu A. Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Rev Panam Salud Publica 16 (2004) 125-130
11. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111 (2003) 1265-1273
12. Lyon B.R., and Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev 51 (1987) 88-134
13. Cheesbrough M. Medical laboratory manual for tropical countries Volume II (1984), Tropical Health Technology, Doddington, UK
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility testing. Document M100-S9. National Committee for Clinical Laboratory Standards, Wayne, PA, USA; 2002.
15. Ako-Nai A.K., Lamikanra A.B., and Onipede A.O. Incidence of pathogenic microorganisms in clinical specimens from hospitals in south-western Nigeria. East Afr Med J 72 (1995) 436-441
16. Farrar W.E. Antibiotic resistance in developing countries. J Infect Dis 152 (1994) 1103-1106
17. O'Brien T.F. Resistance to antibiotics at medical centers in different parts of the world. J Antimicrob Chemother 18 Suppl C (1986) 919-926
18. Lamikanra A., and Ndap R.B. Trimethoprim resistance in urinary tract pathogens in two Nigerian hospitals. J Antimicrob Chemother 3 (1989) 151-154
19. Orrett F.A., and Shurland S.M. Production of β-lactamase in Trinidad: an association with multiple resistance to β-lactam antibiotics. Med Sci Res 24 (1996) 519-522
20. Young H.K., Jesudason M.V., Koshi G., and Anges S.G.B. Trimethoprim resistance amongst urinary pathogens in South India. J Antimicrob Chemother 17 (1986) 615-621
21. Lacey R.W. Multi-resistant Staphylococcus aureus: a suitable cause for inactivity. J Hosp Infect 9 (1987) 103-105
22. Thompson K.S., Sanders W.E., and Sanders C.L. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 33 (1994) 9-15
23. Kuehnert M.J., Hill H.A., Kupronis B.A., Tokars J.I., Solomon S.L., and Jernigan D.B. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 11 (2005) 868-872
24. Voss A., and Doebbeling B.N. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 5 (1995) 101-106
25. Lotsu D.K., Imamura T., and Takamine F. Current status of antimicrobial susceptibility in MRSA isolates typed by coagulase and phage typing in Okinawa. Acta Med Okayama 49 (1995) 81-89
26. Bodonaik N.C., King S.D., and Narla V.R. Antimicrobial resistance in clinical isolates of Staphylococcus aureus at the University Hospital of the West Indies. West Indian Med J 33 (1984) 8-13
27. Gold H.S., and Moellering Jr. R.C. Antimicrobial-drug resistance. N Engl J Med 335 (1996) 1445-1453
28. Mulligan M.E., Murray-Leisure K.A., Ribner B.S., Standiford H.C., John J.F., Korvick J.A., et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 94 (1993) 313-328
29. Anupurba S., Sen M.R., Nath G., Sharma B.M., Gulati A.K., and Mohapatra T.M. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21 (2003) 49-51
30. Balaka B., Agbere A.D., Baeta S., Kessie K., and Assimadi K. Bacterial flora in the genital tract the last trimester of pregnancy. J Gynecol Obstet Biol Reprod (Paris) 32 (2003) 555-561
31. Balaka B., Agbere A., Dagnra A., Baeta S., Kessie K., and Assimadi K. Genital bacterial carriage during the last trimester of pregnancy and early-onset neonatal sepsis. Arch Pediatr 12 (2005) 514-519
32. Dykhuizen R.S., Harvey G., and Gould I.M. The high vaginal swab in general practice: clinical correlates of possible pathogens. Fam Pract 12 (1995) 155-158
33. Muder R.R., Brennen C., Rihs J.D., Wagener M.M., Obman A., Stout J.E., and Yu V.L. Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia. Clin Infect Dis 42 (2006) 46-50
34. Sheth S., and DiNubile M.J. Clinical significance of Staphylococcus aureus bacteriuria without concurrent bacteremia. Clin Infect Dis 24 (1997) 1268-1269
35. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhoj P., and Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162 (2002) 25-32
36. Weems Jr. J.J. The many faces of Staphylococcus aureus infection. Recognizing and managing its life-threatening manifestations. Postgrad Med 110 (2001) 24-36
37. Brumfitt W., and Miller H. Methicillin-resistant: Staphylococcus aureus. N Engl J Med 320 (1989) 1188-1196
38. Massanari R.M., Pfaller M.A., and Wakefield D.S. Implication of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 158 (1988) 702-709
39. Maple P.A.C., Hamilton G.M.T., and Brumfitt W. World-wide antibiotic resistance in methicillin-resistant, Staphylococcus aureus. Lancet 1 (1989) 537-540
40. Markowitz N., Quinn E.L., and Saravolatz L.D. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 117 (1992) 390-398